Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 7/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | BAX | Q07812 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 3/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10570950 | 0.91 | CA4 (0.48) | LTA4HTSHRMGLLFAAHSMN1; SMN2 | |
| SCHEMBL1608968 | 0.87 | CA4 (0.48) | LTA4HTSHRMGLLFAAHSMN1; SMN2 | |
| SCHEMBL19987671 | 0.81 | LTA4H (0.58) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL188026 | 0.79 | CA4 (0.48) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL21174882 | 0.77 | LTA4H (0.48) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL19817037 | 0.76 | LTA4H (0.38) | LTA4HTSHRSMN1; SMN2HPGDCA4 | |
| SCHEMBL10356304 | 0.76 | ACHE (0.50) | TSHRSMN1; SMN2MEN1KMT2AHPGD | |
| SCHEMBL8999368 | 0.75 | LTA4H (0.56) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL19985753 | 0.75 | LTA4H (0.56) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL19985748 | 0.75 | LTA4H (0.56) | LTA4HTSHRNR1H2BAXMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079761-A1 | High-RI siloxane monomers, their polymerization and use | INKRON OY (FI) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079761-A1 | High-RI siloxane monomers, their polymerization and use | IPO9, PPOX, PPID | LTA4H 1437/4885TSHR 4556/4885NR1H2 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.